CliffBio
small molecule

OXYMORPHONE HYDROCHLORIDE

OXYMORPHONE HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyPar →See this company's full patent-cliff portfolio

Drug detail

Brand nameOXYMORPHONE HYDROCHLORIDE
Active ingredientOXYMORPHONE HYDROCHLORIDE
Strength5MG
Dosage formTABLET, EXTENDED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalOctober 2014
Marketing statusDISCN

More from Par

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

OXYMORPHONE HYDROCHLORIDE patent cliff — loss of exclusivity — | CliffBio